Portfolio company
Meddenovo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Deep MedChem
This company develops artificial intelligence software for virtual screening and molecular discovery for pharmaceutical, biotechnology and academic drug discovery teams.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
ProtOS
This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Aizen Therapeutics
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
DreamFold AI
This company develops generative artificial intelligence models for protein design to discover medicines for pharmaceutical and biotechnology researchers.
